中文English
ISSN 1001-5256
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

血管生成素样蛋白在非酒精性脂肪性肝病发展中的作用

郑培玉 安秀琴 刘近春

引用本文:
Citation:

血管生成素样蛋白在非酒精性脂肪性肝病发展中的作用

DOI: 10.3969/j.issn.1001-5256.2021.11.042
基金项目: 

山西省科技成果转化引导专项项目 201904D131030

详细信息
    通信作者:

    刘近春,zxr610624@163.com

  • 中图分类号: R575.5

Role of angiopoietin-like proteins in the development of nonalcoholic fatty liver disease

Research funding: 

Scientific and Technological Achievements Transformation Guidance Special of Shanxi Province, China 201904D131030

  • 摘要: 血管生成素样因子(ANGPTL)是近年来发现的一类与血管生成素在组成上具有同源性,并具有调节血管生成作用的分泌性糖蛋白家族。近年来,越来越多的研究表明ANGPTL在糖脂代谢、炎症和肿瘤中具有重要的作用。众所周知,非酒精性脂肪性肝病(NAFLD)及其疾病谱与代谢、炎症、肿瘤密切相关,现就ANGPTL在NAFLD中的作用作一综述,以期为临床防治NAFLD提供新的思路。

     

  • 图  1  ANGPTL在NAFLD中的作用机制示意图

  • [1] SUO YH, LIU JC. Research advances in the treatment of nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2018, 34(10): 2232-2236. DOI: 10.3969/j.issn.1001-5256.2018.10.038.

    索宇鸿, 刘近春. 非酒精性脂肪性肝病的治疗进展[J]. 临床肝胆病杂志, 2018, 34(10): 2232-2236. DOI: 10.3969/j.issn.1001-5256.2018.10.038.
    [2] SASAKI Y, OHTA M, DESAI D, et al. Angiopoietin like protein 2 (ANGPTL2) promotes adipose tissue macrophage and T lymphocyte accumulation and leads to insulin resistance[J]. PLoS One, 2015, 10(7): e0131176. DOI: 10.1371/journal.pone.0131176.
    [3] HORIO E, KADOMATSU T, MIYATA K, et al. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression[J]. Arterioscler Thromb Vasc Biol, 2014, 34(4): 790-800. DOI: 10.1161/ATVBAHA.113.303116.
    [4] DIJK W, KERSTEN S. Regulation of lipid metabolism by angiopoietin-like proteins[J]. Curr Opin Lipidol, 2016, 27(3): 249-256. DOI: 10.1097/MOL.0000000000000290.
    [5] KERSTEN S. Angiopoietin-like 3 in lipoprotein metabolism[J]. Nat Rev Endocrinol, 2017, 13(12): 731-739. DOI: 10.1038/nrendo.2017.119.
    [6] BARCHETTA I, CIMINI FA, CHIAPPETTA C, et al. Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity[J]. Liver Int, 2020, 40(9): 2139-2147. DOI: 10.1111/liv.14554.
    [7] YANG LY, WANG Y, XU YC, et al. Effect of angiopoietin-like 4 in the diagnosis of nonalcoholic fatty liver[J]. J Capit Med Univ, 2020, 41(1): 31-34. DOI: 10.3969/j.issn.1006-7795.2020.01.006.

    杨龙艳, 王岩, 许月超, 等. 血管生成素样蛋白4在非酒精性脂肪肝诊断中的应用效果分析[J]. 首都医科大学学报, 2020, 41(1): 31-34. DOI: 10.3969/j.issn.1006-7795.2020.01.006.
    [8] ALGHANIM G, QADDOUMI MG, ALHASAWI N, et al. Higher levels of ANGPTL5 in the circulation of subjects with obesity and type 2 diabetes are associated with insulin resistance[J]. Front Endocrinol (Lausanne), 2019, 10: 495. DOI: 10.3389/fendo.2019.00495.
    [9] KIM MJ, NAMKUNG J, CHANG JS, et al. Leptin regulates the expression of angiopoietin-like 6[J]. Biochem Biophys Res Commun, 2018, 502(3): 397-402. DOI: 10.1016/j.bbrc.2018.05.180.
    [10] LEE YH, LEE SG, LEE CJ, et al. Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: Animal and human studies[J]. Sci Rep, 2016, 6: 24013. DOI: 10.1038/srep24013.
    [11] HONG BS, LIU J, ZHENG J, et al. Angiopoietin-like protein 8/betatrophin correlates with hepatocellular lipid content independent of insulin resistance in non-alcoholic fatty liver disease patients[J]. J Diabetes Investig, 2018, 9(4): 952-958. DOI: 10.1111/jdi.12792.
    [12] GARCÍA-MONZÓN C, PETROV PD, REY E, et al. Angiopoietin-like protein 8 is a novel vitamin D receptor target gene involved in nonalcoholic fatty liver pathogenesis[J]. Am J Pathol, 2018, 188(12): 2800-2810. DOI: 10.1016/j.ajpath.2018.07.028.
    [13] BARCHETTA I, CIMINI FA, CHIAPPETTA C, et al. Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity[J]. Liver Int, 2020, 40(9): 2139-2147. DOI: 10.1111/liv.14554.
    [14] JAHN D, DORBATH D, SCHILLING AK, et al. Intestinal vitamin D receptor modulates lipid metabolism, adipose tissue inflammation and liver steatosis in obese mice[J]. Biochim Biophys Acta Mol Basis Dis, 2019, 1865(6): 1567-1578. DOI: 10.1016/j.bbadis.2019.03.007.
    [15] MEHTA N, QAMAR A, QU L, et al. Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits[J]. Arterioscler Thromb Vasc Biol, 2014, 34(5): 1057-1063. DOI: 10.1161/ATVBAHA.113.302802.
    [16] TIKKA A, JAUHIAINEN M. The role of ANGPTL3 in controlling lipoprotein metabolism[J]. Endocrine, 2016, 52(2): 187-193. DOI: 10.1007/s12020-015-0838-9.
    [17] GRAHAM MJ, LEE RG, BRANDT TA, et al. Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides[J]. N Engl J Med, 2017, 377(3): 222-232. DOI: 10.1056/NEJMoa1701329.
    [18] WANG Y, LIU LM, WEI L, et al. Angiopoietin-like protein 4 improves glucose tolerance and insulin resistance but induces liver steatosis in high-fat-diet mice[J]. Mol Med Rep, 2016, 14(4): 3293-3300. DOI: 10.3892/mmr.2016.5637.
    [19] LA PAGLIA L, LISTÌ A, CARUSO S, et al. Potential role of ANGPTL4 in the cross talk between metabolism and cancer through PPAR signaling pathway[J]. PPAR Res, 2017, 2017: 8187235. DOI: 10.1155/2017/8187235.
    [20] ZHANG R. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking[J]. Open Biol, 2016, 6(4): 150272. DOI: 10.1098/rsob.150272.
    [21] KITAZAWA M, NAGANO M, MASUMOTO KH, et al. Angiopoietin-like 2, a circadian gene, improves type 2 diabetes through potentiation of insulin sensitivity in mice adipocytes[J]. Endocrinology, 2011, 152(7): 2558-2567. DOI: 10.1210/en.2010-1407.
    [22] WANG Y, MCNUTT MC, BANFI S, et al. Hepatic ANGPTL3 regulates adipose tissue energy homeostasis[J]. Proc Natl Acad Sci U S A, 2015, 112(37): 11630-11635. DOI: 10.1073/pnas.1515374112.
    [23] KANG SG, YI HS, CHOI MJ, et al. ANGPTL6 expression is coupled with mitochondrial OXPHOS function to regulate adipose FGF21[J]. J Endocrinol, 2017, 233(1): 105-118. DOI: 10.1530/JOE-16-0549.
    [24] RONG GUO X, LI WANG X, CHEN Y, et al. ANGPTL8/betatrophin alleviates insulin resistance via the Akt-GSK3β or Akt-FoxO1 pathway in HepG2 cells[J]. Exp Cell Res, 2016, 345(2): 158-167. DOI: 10.1016/j.yexcr.2015.09.012.
    [25] ZHANG Z, WU H, DAI L, et al. ANGPTL8 enhances insulin sensitivity by directly activating insulin-mediated AKT phosphorylation[J]. Gene, 2020, 749: 144707. DOI: 10.1016/j.gene.2020.144707.
    [26] COX AR, BARRANDON O, CAI EP, et al. Resolving discrepant findings on ANGPTL8 in β-cell proliferation: A collaborative approach to resolving the betatrophin controversy[J]. PLoS One, 2016, 11(7): e0159276. DOI: 10.1371/journal.pone.0159276.
    [27] SAHARINEN P, EKLUND L, ALITALO K. Therapeutic targeting of the angiopoietin-TIE pathway[J]. Nat Rev Drug Discov, 2017, 16(9): 635-661. DOI: 10.1038/nrd.2016.278.
    [28] FU X, CHEN H, HAN S. C16 peptide and angiopoietin-1 protect against LPS-induced BV-2 microglial cell inflammation[J]. Life Sci, 2020, 256: 117894. DOI: 10.1016/j.lfs.2020.117894.
    [29] CHANDEL S, SATHIS A, DHAR M, et al. Hyperinsulinemia promotes endothelial inflammation via increased expression and release of Angiopoietin-2[J]. Atherosclerosis, 2020, 307: 1-10. DOI: 10.1016/j.atherosclerosis.2020.06.016.
    [30] KADOMATSU T, ENDO M, MIYATA K, et al. Diverse roles of ANGPTL2 in physiology and pathophysiology[J]. Trends Endocrinol Metab, 2014, 25(5): 245-254. DOI: 10.1016/j.tem.2014.03.012.
    [31] LU Z, HE B, CHEN Z, et al. Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway[J]. BMC Immunol, 2020, 21(1): 28. DOI: 10.1186/s12865-020-00358-9.
    [32] HESS AL, CARAYOL J, BLÆDEL T, et al. Analysis of circulating angiopoietin-like protein 3 and genetic variants in lipid metabolism and liver health: The DiOGenes study[J]. Genes Nutr, 2018, 13: 7. DOI: 10.1186/s12263-018-0597-3.
    [33] EL-SHAL AS, ZIDAN HE, RASHAD NM, et al. Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma[J]. Cytokine, 2017, 96: 75-86. DOI: 10.1016/j.cyto.2017.03.006.
    [34] ZHU P, GOH YY, CHIN HF, et al. Angiopoietin-like 4: A decade of research[J]. Biosci Rep, 2012, 32(3): 211-219. DOI: 10.1042/BSR20110102.
    [35] CINKAJZLOVA A, LACINOVA Z, KLOUCKOVA J, et al. Angiopoietin-like protein 6 in patients with obesity, type 2 diabetes mellitus, and anorexia nervosa: The influence of very low-calorie diet, bariatric surgery, and partial realimentation[J]. Endocr Res, 2017, 42(1): 22-30. DOI: 10.3109/07435800.2016.1169544.
    [36] POLYZOS SA, KOUNTOURAS J, MANTZOROS CS. Leptin in nonalcoholic fatty liver disease: A narrative review[J]. Metabolism, 2015, 64(1): 60-78. DOI: 10.1016/j.metabol.2014.10.012.
    [37] POLYZOS SA, ARONIS KN, KOUNTOURAS J, et al. Circulating leptin in non-alcoholic fatty liver disease: A systematic review and meta-analysis[J]. Diabetologia, 2016, 59(1): 30-43. DOI: 10.1007/s00125-015-3769-3.
    [38] REN G, KIM JY, SMAS CM. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism[J]. Am J Physiol Endocrinol Metab, 2012, 303(3): E334-351. DOI: 10.1152/ajpendo.00084.2012.
    [39] CHEN HA, KUO TC, TSENG CF, et al. Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma[J]. Hepatology, 2016, 64(5): 1637-1651. DOI: 10.1002/hep.28773.
    [40] GAO L, GE C, FANG T, et al. ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2015, 30(2): 396-404. DOI: 10.1111/jgh.12702.
    [41] YU H, ZHANG H, LI D, et al. Effects of ANGPTL3 antisense oligodeoxynucleotides transfection on the cell growths and invasion of human hepatocellular carcinoma cells[J]. Hepatogastroenterology, 2011, 58(110-111): 1742-1746. DOI: 10.5754/hge10647.
    [42] KOYAMA T, OGAWARA K, KASAMATSU A, et al. ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer[J]. Cancer Med, 2015, 4(5): 759-769. DOI: 10.1002/cam4.418.
    [43] HAN S, XU W, WANG Z, et al. Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironment[J]. Oncotarget, 2016, 7(25): 37773-37789. DOI: 10.18632/oncotarget.9329.
    [44] PARRI M, PIETROVITO L, GRANDI A, et al. Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer[J]. Angiogenesis, 2014, 17(4): 881-896. DOI: 10.1007/s10456-014-9435-4.
  • 加载中
图(1)
计量
  • 文章访问数:  90
  • HTML全文浏览量:  118
  • PDF下载量:  25
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-03-14
  • 录用日期:  2021-04-19
  • 出版日期:  2021-11-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回